Christy Kim1, Elizabeth delaRiva-Velasco1, Arvind Budhram1, Folashade Farri1, Daniel Krich1, Sheila S Nolan2, Suzette Gjonaj1, Lisa Paul3, Allen J Dozor1, John J Welter1. 1. New York Medical College and Maria Fareri Children's Hospital at Westchester Medical Center Division of Pediatric Pulmonology, Allergy and Sleep Medicine and the Armond V. Mascia Cystic Fibrosis Center, Valhalla, NY, USA. 2. New York Medical College and Maria Fareri Children's Hospital at Westchester Medical Center Division of Pediatric Infectious Disease, Valhalla, NY, USA. 3. Westchester Medical Center, Division of Pulmonary, Critical Care and Sleep Medicine, Valhalla, NY, USA.
Abstract
BACKGROUND: The 2013 Cystic Fibrosis Foundation's Infection Prevention and Control Guideline (CFF IP&C) was developed to reduce the risk of acquisition and transmission of respiratory pathogens in patients with cystic fibrosis (CF). OBJECTIVE: We hypothesised that the incidence of common CF respiratory pathogens would decrease at our centre after implementation of the guideline. METHODS: All patients with CF seen at our centre from August 2012 through August 2017 who had respiratory cultures were included. Patients were excluded from incidence analysis if they did not have at least one culture per year. Quarterly data were collected for one year before and three years after implementation of the guidelines to determine the incidence and prevalence of seven organisms commonly found in respiratory cultures of patients with CF. RESULTS: Quarterly and annual incidence and prevalence rates of common organisms did not change during the study period. DISCUSSION: There were no significant differences in the incidence or prevalence of common respiratory organisms in the first three years after implementation of the CF IP&C guideline. Long-term follow-up is needed to determine if changes occur over time.
BACKGROUND: The 2013 Cystic Fibrosis Foundation's Infection Prevention and Control Guideline (CFF IP&C) was developed to reduce the risk of acquisition and transmission of respiratory pathogens in patients with cystic fibrosis (CF). OBJECTIVE: We hypothesised that the incidence of common CF respiratory pathogens would decrease at our centre after implementation of the guideline. METHODS: All patients with CF seen at our centre from August 2012 through August 2017 who had respiratory cultures were included. Patients were excluded from incidence analysis if they did not have at least one culture per year. Quarterly data were collected for one year before and three years after implementation of the guidelines to determine the incidence and prevalence of seven organisms commonly found in respiratory cultures of patients with CF. RESULTS: Quarterly and annual incidence and prevalence rates of common organisms did not change during the study period. DISCUSSION: There were no significant differences in the incidence or prevalence of common respiratory organisms in the first three years after implementation of the CF IP&C guideline. Long-term follow-up is needed to determine if changes occur over time.
Authors: Jonathan B Zuckerman; Sarah A Clock; B Stephen Prato; James J McDevitt; Juyan Julia Zhou; Laurie W Leclair; F Lee Lucas; Lisa Saiman Journal: Am J Respir Crit Care Med Date: 2015-03-01 Impact factor: 21.405
Authors: Ruth Ann Luna; Laura A Millecker; C Renee Webb; Sally K Mason; Elaine M Whaley; Jeffrey R Starke; Peter W Hiatt; James Versalovic Journal: J Clin Microbiol Date: 2013-01-09 Impact factor: 5.948
Authors: Lisa Saiman; Jane D Siegel; John J LiPuma; Rebekah F Brown; Elizabeth A Bryson; Mary Jo Chambers; Veronica S Downer; Jill Fliege; Leslie A Hazle; Manu Jain; Bruce C Marshall; Catherine O'Malley; Suzanne R Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A Robinson; Kathryn A Sabadosa; H Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J Weber Journal: Infect Control Hosp Epidemiol Date: 2014-07-01 Impact factor: 3.254
Authors: Elizabeth L Salsgiver; Aliza K Fink; Emily A Knapp; John J LiPuma; Kenneth N Olivier; Bruce C Marshall; Lisa Saiman Journal: Chest Date: 2016-01-12 Impact factor: 9.410
Authors: Luke D Knibbs; Graham R Johnson; Timothy J Kidd; Joyce Cheney; Keith Grimwood; Jacqueline A Kattenbelt; Peter K O'Rourke; Kay A Ramsay; Peter D Sly; Claire E Wainwright; Michelle E Wood; Lidia Morawska; Scott C Bell Journal: Thorax Date: 2014-04-17 Impact factor: 9.139
Authors: Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli Journal: Int J Mol Sci Date: 2020-05-08 Impact factor: 5.923